A nurse‐led intervention in patients with newly diagnosed cancer and Type 2 diabetes: A pilot randomized controlled trial feasibility study by Scarton, Lisa, Nelson, Tarah, Jo, Ara, O’Neal, LaToya J., Yao, Yingwei, Huggins, Shavondra, Legaspi, Anatolia B., McClaren, Mariah J., Cabassa, Jake S., Burgos Melendez, Joan M., Munoz‐Pena, Juan M., Markham, Merry J., Murphy, Martina C., Chatzkel, Jonathan A., Rogers, Sherise, George, Thomas J.

Get full text

Predicting Complete Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer by Miyagi, Hiroko, Kwenda, Elizabeth, Ramnaraign, Brian H, Chatzkel, Jonathan A, Brisbane, Wayne G, O'Malley, Padraic, Crispen, Paul L

Get full text

Atezolizumab plus tivozanib for immunologically cold tumor types: the IMMCO-1 trial by Ramnaraign, Brian H, Lee, Ji-Hyun, Ali, Azka, Rogers, Sherise C, Fabregas, Jesus C, Thomas, Ryan M, Allegra, Carmen J, Sahin, Ilyas, DeRemer, David L, George, Thomas J, Chatzkel, Jonathan A

Get full text

Cecal Metastasis of Clear Cell Renal Cell Carcinoma After Previous Nephrectomy by Lin, Rick Y, Shen, Steve, Donabedian, Patrick L, Kiani, Calvin, Kresak, Jesse L, Chatzkel, Jonathan A, Dakhoul, Lara

Get full text

Red nucleus degeneration in hypertrophic olivary degeneration after pediatric posterior fossa tumor resection: use of susceptibility-weighted imaging (SWI) by Vossough, Arastoo, Ziai, Pouya, Chatzkel, Jonathan A.

Get full text

Metronidazole-induced cerebellar toxicity by Chatzkel, Jonathan A., Vossough, Arastoo

Get full text

Abstract B130: Feasibility metric outcomes: A nurse-led intervention to identify and manage undiagnosed type 2 diabetes in patients with newly diagnosed cancer by Scarton, Lisa, Nelson, Tarah, Yao, Yingwei, Huggins, Shavondra, Jo, Ara, O'Neal, LaToya J., George, Thomas J., Munoz-Pena, Juan M., Markham, Merry J., Murphy, Martina C., Chatzkel, Jonathan A., Rogers, Sherise

Get full text

Cecal Metastasis of Clear Cell Renal Cell Carcinoma After Previous Nephrectomy by Lin, Rick Y, Shen, Steve, Donabedian, Patrick L, Kiani, Calvin, Kresak, Jesse L, Chatzkel, Jonathan A, Dakhoul, Lara

Get full text

Updates on Immunotherapy and Immune Landscape in Renal Clear Cell Carcinoma by Kim, Myung-Chul, Jin, Zeng, Kolb, Ryan, Borcherding, Nicholas, Chatzkel, Jonathan Alexander, Falzarano, Sara Moscovita, Zhang, Weizhou

Get full text

Approaches to Treating High Risk and Advanced Renal Cell Carcinoma (RCC): Key Trial Data That Impacts Treatment Decisions in the Clinic by Chatzkel, Jonathan, Fishman, Mayer, Ramnaraign, Brian, O'Malley, Padraic, Sonpavde, Guru P

Get full text

Coordinated Pembrolizumab and High Dose IL-2 (5-in-a-Row Schedule) for Therapy of Metastatic Clear Cell Renal Cancer by Chatzkel, Jonathan, Schell, Michael J., Chahoud, Jad, Zhang, Jingsong, Jain, Rohit, Swank, Jennifer, Ludlow, Steve, Lombardi, Kristina, Lucas, Yesenia, Croft, Cortlin, Rembisz, Jennifer, Jameel, Gigi, Fishman, Mayer

Get full text

Circulating tumor cells and γH2AX as biomarkers for responsiveness to radium-223 in advanced prostate cancer patients by Chatzkel, Jonathan, Mocha, Jesse, Smith, Johnna, Zhou, Jun-Min, Kim, Youngchul, El-Haddad, Ghassan, Zhang, Jingsong

Get full text

Correlation of Ki-67 Proliferative Antigen Expression and Tumor Response to Induction Chemotherapy Containing Cell Cycle-Specific Agents in Head and Neck Squamous Cell Carcinoma by Chatzkel, Jonathan, Lewis, James S., Ley, Jessica C., Wildes, Tanya M., Thorstad, Wade, Gay, Hiram, Daly, Mackenzie, Jackson, Ryan, Rich, Jason, Paniello, Randal, Nussenbaum, Brian, Liu, Jingxia, Siegel, Barry A., Dehdashti, Farrokh, Adkins, Douglas

Get full text